Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology

"Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenesis R&D and business development in oncology. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers - Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology and Angiogenesis in Oncology: Drug Pipeline Update 2007*.

The Package Includes:

A progress analysis on current and emerging drugs

Information on most companies active in anti-angiogenesis and vascular targeting R&D

Information on key industry related anti-angiogenesis and vascular targeting projects

Data from most important clinical trials

Information on early developmental stage projects

Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

Tracking cutting edge companies, therapies and new technologies

Rapid identification of partners & competitors

Laying down a comprehensive framework for further analysis of the field

Producing presentations surrounding the development of anti-angiogenesis and vascular targeting therapeutics

Identifying emerging anti-angiogenesis and vascular targeting products & key areas of pharmaceutical R&D

*BioSeekers CD-ROM searchable database reflects the most recent advances in the field of anti-angiogenesis and vascular targeting development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker Group CD-ROM searchable databases is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker Group’s CD-ROM searchable databases give better overview and specific search capabilities.

May 2007 CD-ROM
Price: $4,795.00 / GBP2,397.50